WO2006010474A1 - Verfahren zur herstellung von 3-phenyl(thio)uracilen und - dithiouracilen - Google Patents
Verfahren zur herstellung von 3-phenyl(thio)uracilen und - dithiouracilen Download PDFInfo
- Publication number
- WO2006010474A1 WO2006010474A1 PCT/EP2005/007577 EP2005007577W WO2006010474A1 WO 2006010474 A1 WO2006010474 A1 WO 2006010474A1 EP 2005007577 W EP2005007577 W EP 2005007577W WO 2006010474 A1 WO2006010474 A1 WO 2006010474A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- alkyl
- phenyl
- hydrogen
- thio
- Prior art date
Links
- 0 *S(NC([Al]N(C(C=C(C(F)(F)F)N1)=O)C1=O)=O)(=O)=O Chemical compound *S(NC([Al]N(C(C=C(C(F)(F)F)N1)=O)C1=O)=O)(=O)=O 0.000 description 5
- XGJBKVHUOUXGPH-UHFFFAOYSA-N NC(O1)=NC(C(F)(F)F)=CC1=O Chemical compound NC(O1)=NC(C(F)(F)F)=CC1=O XGJBKVHUOUXGPH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
Definitions
- the present invention relates to a process for the preparation of 3-phenyl (thio) uracils and dithiouracils of the formula I.
- R 1 is hydrogen, C 1 -C 6 -alkyl, Ci-C 4 cyanoalkyl, C r C 6 haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 3 -C 6 -alkyl kinyl, C 3 -C 6 haloalkynyl, Phe nyl-Ci-C 4 alkyl or amino;
- R 2 and R 3 are independently hydrogen, C 1 -C 6 -alkyl, C r C 6 haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 alkenyl,
- X 1 , X 2 and X 3 are independent of each other
- Ar is phenyl which may be partially or fully halogenated and / or may carry one to three radicals from the group cyano, C r C 4 alkyl or C r C 4 haloalkyl, and
- A is a radical derived from a primary or secondary amine or NH 2 .
- Penyluracils which in the meta position to the uracil ring on the phenyl ring carry a heterocycle or an unsaturated ester, thioester or amide radical which is linked to the phenyl ring via an oxygen or sulfur atom, are known from WO 04/056785.
- 3-phenyluracils of the general formula I and the corresponding thio- and dithiouracils are known in principle from WO 01/83459.
- a disadvantage of this procedure is that the benzoic acid used is obtainable only by cleavage with boron tribromide with a corresponding salt attack from the preceding ester.
- the yield of the condensation with sulfonic acid diamonds is only between 16 and 45%.
- the detour via a previously prepared acid chloride leads in only 26% yield to the desired Benzoylsulfonklarediamid.
- the method B has the disadvantage that the halogenaromatic used must be provided um ⁇ only by way of a Sandmeyer reaction.
- the selectivity of the reaction with respect to the halogen radical in the presence of further halogen substituents on Ar is unsatisfactory.
- the oxazinone used has to be prepared in a complicated manner by reacting an aminocrotonic acid ester with a dialkylcarbamoyl chloride and subsequent cyclization with phosphorus oxychloride, phosphorus pentachloride or oxalyl chloride. This process is also not sufficiently economical due to the starting materials used and the reaction stages.
- the object of the present invention is therefore to provide processes for the preparation of 3-phenyl (thio) uracils and dithiouracils of the formula I which afford the 3-phenyl (thio) uracils and dithiouracils of the formula I in high yields and good yields Purity provides, and also overcomes the disadvantages of the prior art.
- a further object of the present invention is to provide a simple and easy-to-handle process for the preparation of carbamates of the formula II which gives the carbamates of the formula M in high yields and good purity.
- the present invention therefore provides a process for preparing the above-defined 3-phenyl (thio) uracils and dithiouracils of the formula I, which comprises reacting carbamates of the formula II with an enamine of the formula III.
- the carbamates of the formula II can in turn be prepared analogously to known processes of the prior art (eg Houben-Weyl, Methoden der organischen Chemie, E5, 1985, pp. 972-980, and VIII 1 p 10, JB Press et al., J. Het. Chem., 23, 6, 1986, pp. 1821-1828; I. Vanthey et al., Tetrahedron Lett. 41, 33, 2000, pp. 6347-6350 M. Belley et al., Synlett, 2, 2001, pp. 222-225) from amines of formula IV
- the process according to the invention preferably also comprises the provision of the carbamates of the formula II in this way.
- the carbamates of the formula II are novel and are also the subject of the present invention as starting materials or intermediates in the process according to the invention.
- All hydrocarbon chains ie all alkyl, haloalkyl, cyanoalkyl, cyanoalkoxy, alkoxy, haloalkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, Alkenyl, haloalkenyl, alkenyloxy, haloalkenyloxy, alkynyl, haloalkynyl, alkynyloxy, haloalkynyloxy, alkoxyalkoxy and alkylthioalkoxy moieties may be straight-chain or branched. Unless otherwise stated, halogenated substituents preferably carry one to five identical or different halogen atoms. The meaning halogen is in each case fluorine, chlorine, bromine or iodine.
- - C 1 -C 4 -alkyl for example methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-methylpropyl, 2-methylpropyl and 1, 1-dimethylethyl;
- C 1 -C 6 -alkyl C 1 -C 4 -alkyl, as mentioned above, and also, for example, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2 , 2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1, 1, 2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-3-methylpropyl ;
- C 1 -C 4 -alkylcarbonyl for example methylcarbonyl, ethylcarbonyl, propylcarbonyl, 1-methylethylcarbonyl, butylcarbonyl, 1-methylpropylcarbonyl, 2-methylpropylcarbonyl or 1, 1-dimethylethylcarbonyl;
- C 3 -C 8 -cycloalkyl and the cycloalkyl parts of C 3 -C 8 -cycloalkoxy for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cycloocytyl;
- C 3 -C 8 -cycloalkenyl for example cyclopropenyl, cyclopropen-2-yl, cyclobuten-1-yl, cyclobuten-2-yl, cyclopenten-1-yl, cyclopent-2-en-1-yl, Cyclopent-2,4-dien-1-yl, cyclophenex-1-yl, cyclohen-2-en-1-yl, cyclohen-3-en-1-yl; Cyclohepten-1-yl, cyclohept-2-en-1-yl, cyclohept-3-en-1-yl, cycloocten-1-yl, cyclooct-2-en-1-yl, cyclooct-en-1-yl, cyclooct-en-1-yl, cyclooct-
- Tetrahydropyrrol-1-yl e.g. Tetrahydropyrrol-1-yl, tetrahydropyrazol-1-yl, tetrahydroisoxazol-2-yl, tetrahydroisothiazol-2-yl, tetrahydroimidazol-1-yl, tetrahydrooxazol-3-yl, tetrahydrothiazol-3-yl;
- Triazolin-4-yl 1,2,3- ⁇ 2 -triazolin-5-yl, 1, 2,4- ⁇ 2 -triazolin-3-yl, 1,2,4- ⁇ 2 -triazolin-5-yl , 1, 2,4- ⁇ 3 -triazolin-3-yl, 1, 2,4- ⁇ 3 -triazolin-5-yl, 1, 2,4- ⁇ 1 -triazolin-2-yl, 1,2, 4-triazolin-3-yl, 3H-1, 2,4-dithiazol-5-yl, 2H-1, 3,4-dithiazol-5-yl, 2H-1,3,4-oxathiazol-5-yl;
- Piperidine-1-yl e.g. Piperidine-1-yl, hexahydropyrimidin-1-yl, hexahydropyrazine-1-yl, hexahydropyridazin-1-yl, tetrahydro-1,3-oxazin-3-yl, tetrahydro-1,3-thiazin-3-yl, Tetrahydro-1,4-thiazin-4-yl, tetrahydro-1,4-oxazin-4-yl, tetrahydro-1,2-oxazine-2-yl;
- Tetrahydropyrimidin-6-yl 1,2,3,4-tetrahydropyrazine-2-yl, 1,2,3,4-tetrahydropyrazine-5-yl, 1,2,3,4-tetrahydropyrimidine-2-yl yl, 1, 2,3,4-tetrahydropyrimidin-4-yl, 1,2,3,4-tetrahydropyrimidin-5-yl, 1,2,3,4-tetrahydropyrimidin-6-yl, 2,3- Dihydro-1,4-thiazin-2-yl, 2,3-dihydro-1,4-thiazin-3-yl, 2,3-dihydro-1, 4-thiazine-5-yl, 2,3-dihydro- 1, 4-thiazine-6-yl, 2H-1,2-oxazin-3-yl, 2H-1, 2
- C 3 -C 6 alkenyl for example, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1 -Methyl-2-propenyl, 2-
- C 3 -C 6 -alkynyl for example 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butylyl, 1-methyl
- C 2 -C 6 -alkynyl C 3 -C 6 -alkynyl as mentioned above and ethynyl;
- Ci-C4-haloalkyl a Ci-C 4 -alkyl radical as mentioned above which is partially or fully substituted by fluorine, chlorine, bromine and / or iodine is substituted, eg chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoro- methyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro 2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl,
- C 3 -C 6 haloalkynyl and Halogenalkinylmaschine of C 3 -C 6 haloalkynyloxy a C 3 -C 6 -alkynyl as mentioned above which is partially or fully substituted by fluorine, iodine, chlorine, bromine and / or substituted, for example, 1,1-difluoro-prop-2-yn-1-yl, 3-iodo-prop-2-yn-1-yl, 4-fluorobut-2-yn-1-yl, 4-chlorobut-2in-1 -yl, 1, 1-difluorobut-2-yn-1-yl,
- C 1 -C 4 -cyanoalkyl eg cyanomethyl, 1-cyanoeth-1-yl, 2-cyanoeth-1-yl, 1-cyano-prop-1-yl, 2-cyanoprop-1-yl, 3-cyanopropane 1-yl, 1-cyanoprop-2-yl, 2-cyanoprop-2-yl, 1-cyanobut-1-yl, 2-cyanobut-1-yl, 3-cyanobut-1-yl, 4-cyanobut-1 yl, 1-cyano-but-2-yl, 2-cyanobut-2-yl, 1-cyanobut-3-yl, 2-cyanobut-3-yl, 1-cyano-2-methyl-prop-3-yl, 2-cyano-2-methyl-prop-3-yl, 3-cyano-2-methyl-prop-3-yl and 2-cyano-methyl-prop-2-yl;
- C 1 -C 4 -alkoxy for example methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy and 1, 1-dimethylethoxy;
- C 1 -C 4 -alkoxy C 1 -C 4 -alkoxy as mentioned above, and also, for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methoxylbutoxy, 1, 1-dimethylpropoxy, 1, 2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1, 3-dimethylbutoxy , 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1, 1, 2-trimethylpropoxy, 1, 2,2-trimethylpropoxy, 1-ethyl 1-methylpropoxy and 1-ethyl-2-methylpropoxy;
- C 2 -C 6 -alkenyloxy for example ethen-1-yloxy, ethen-2-yloxy, prop-1-en-1-yloxy, prop-2-en-1-yloxy, 1-methylethenyloxy, butene-1 yloxy, buten-2-yloxy, buten-3-yloxy, 1-methylprop-1-en-1-yloxy, 2-methyl-prop-1-en-1-yloxy, 1-methyl-prop-2- en-1-yloxy, 2- Methyl-prop-2-en-1-yloxy, penten-1-yloxy, penten-2-yloxy, penten-3-yloxy, peten-4-yloxy, 1-methylbut-1-en-1-yloxy, 2-methylbut-1-en-1-yloxy, 3-methylbut-1-en-1-yloxy, 1-methylbut-2-en-1-yloxy, 2-methylbut-2-yl en-1-yloxy, 3-methylbut-2-en-1-yloxy, 1-methylbut
- C 3 -C 6 -alkynyloxy for example, prop-1-yn-1-yyloxy, prop-2-yn-1-yyloxy, but-1-yn-1-ynyloxy, but-1-yn-3-yloxy, But-1-yn-4-yloxy, but-2-yn-1-yyloxy, pent-1-yn-1-ynyloxy, pent-1-yn-3-yloxy,
- Pent-1-yn-4-yloxy pent-1-yn-5-yloxy, pent-2-yn-1-yxylo, pent-2-yn-4-yloxy, pent-yn-5-yloxy, 3-methylbut-1-yn-3-yloxy, 3-methylbut-1-yn-4-yloxy, hex-1-yn-1-ynyloxy, hex-1-yn-3-yloxy, hexyl 1-yn-4-yloxy, hex-1-yn-5-yloxy, hex-1-yn-6-yloxy, hex-2-yn-1-yloxy, hex-2-yn-4-yloxy, hexyl 2-yn-5-yloxy, hex-2-yn-6-yloxy, hex-3-yn-1-ynyloxy, hex-3-yn-2-yloxy, 3-methylpent-1-yn-1-yloxy, 3-Methyl
- - C ⁇ -C t -haloalkoxy a C
- Ci-Ce-haloalkoxy C 1 -C 4 -HaIoQeHaIkOXy as mentioned above, and for example 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6- Bromohexoxy, 6-iodohexoxy and dodafafluorohexoxy;
- Ci-C 4 -alkoxy-C 2 -C 4 alkoxy C 1 -C 4 -alkoxy as mentioned above substitu ⁇ jewes C 2 -C 4 -alkoxy, eg for 2- (methoxy) ethoxy, 2- (Ethoxy) ethoxy, 2- (propoxy) ethoxy, 2- (1-methylethoxy) ethoxy, 2- (butoxy) ethoxy, 2- (1-methylpropoxy) ethoxy, 2- (2-methylpropoxy) ethoxy, 2- (1,1-dimethylethoxy) ethoxy, 2- (methoxy) propoxy, 2- (ethoxy) propoxy, 2- (propoxy) propoxy, 2- (1-methylethoxy) propoxy, 2- (butoxy) propoxy, 2- (1-methylpropoxy) propoxy, 2- (2-methylpropoxy) propoxy, 2-
- C 1 -C 4 alkoxycarbonyl for example, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl, 1-methylethoxycarbonyl, butoxycarbonyl, 1-methylpropoxycarbonyl, 2-methylpropoxycarbonyl or 1, 1-dimethylethoxycarbonyl;
- Or-alkylthio e.g. Methylthio, ethylthio, propylthio, 1-methylethylthio, butylthio, 1-methylpropylthio, 2-methylpropylthio and 1,1-dimethylethylthio;
- C 1 -C -alkylthio C 1 -C 4 -alkylthio as mentioned above, and also, for example, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1, 2-dimethylpropylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1, 1-dimethylbutylthio, 1, 2-dimethylbutylthio, 1, 3-dimethylbutylthio, 2,2-dimethylbutylthio, 2, 3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1, 1, 2-trimethylpropylthio
- C 1 -C 4 -alkylamino for example methylamino, ethylamino, propylamino, 1-methylethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1,1-dimethylethylamino;
- C 1 -C 4 -alkylamino carbonyl for example methylaminocarbonyl, ethylaminocarbonyl, propylaminocarbonyl, 1-methylethylaminocarbonyl, butylaminocarbonyl, 1-methylpropylaminocarbonyl, 2-methylpropylaminocarbonyl or 1,1-dimethylethylaminocarbonyl;
- alkylaminocarbonyl for example N, N-dimethylaminocarbonyl, N, N-diethyl-aminocarbonyl, N 1 N-di- (I-methylethyl) aminocarbonyl, N, N-dipropylaminocarbonyl, N, N-Dibutylaminocarbonyl, N 1 N-di- (I -methylpropyl) aminocarbonyl, N, N-di- (2-methylpropyl) aminocarbonyl, N, N-di (1, 1-dimethylethyl) aminocarbonyl, N-ethyl-N- methylaminocarbonyl, N -Methyl-N-propylaminocarbonyl, N-methyl-N- (1-methylethyl) aminocarbonyl, N-butyl-N-methylaminocarbonyl, N-methyl-N- (1-methylpropyl) aminocarbonyl, N-butyl-N-methylamin
- All phenyl rings are preferably unsubstituted or carry one to three halogen atoms and / or one nitro group, one cyano radical and / or one or two methyl, trifluoromethyl, methoxy or trifluoromethoxy substituents.
- variables R 1 , R 2 and R 3 individually or in combination, have the following meanings:
- R 1 is hydrogen, C 1 -C 6 -alkyl, Ci-C 4 cyanoalkyl, C r C 6 haloalkyl, C 3 -C 8 - cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 3 -C 6 alkynyl, C 3 -C 6 haloalkynyl or phenyl-C 1 -C 4 alkyl; very preferably hydrogen or C 1 -C 4 -alkyl, particularly preferably hydrogen, methyl or ethyl, in particular preferably methyl;
- R 2 is hydrogen, C r C 4 alkyl or Ci-C 4 haloalkyl, more preferably hydrogen, methyl, difluoromethyl or trifluoromethyl, most preferably trifluoromethyl;
- R 3 is hydrogen or C 1 -C 4 -alkyl, particularly preferably hydrogen.
- X 1, X 2 and X 3 are each oxygen.
- the indicated group Ar preferably represents a group of the general formula Ar-1
- R a , R b , R c and R d independently of one another are hydrogen, halogen, cyano or dC 4 -haloalkyl.
- variables R a, R b, R 0 and R d each comprise alone or in combination the following meanings:
- R a is hydrogen, halogen or cyano, particularly preferably hydrogen, fluorine, chlorine or cyano, very preferably hydrogen, chlorine or cyano, very preferably hydrogen or chlorine;
- R b is hydrogen
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R d is hydrogen.
- the specified radical A derived from a primary or secondary amine generally represents a group of the formula -NR 4 R 5 , in which the variables R 4 and R 5 independently of one another have the following meanings:
- R 4 , R 5 is hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl, where the three last-mentioned radicals are represented by a radical selected from the group CN, NO 2 , C 1 -C 4 -alkoxy, C 1 -C 4 -AIkVItNo, formyl, C 1 -C 4 -AIkVl- carbonyl, C- ⁇ -C 4 -alkoxycarbonyl, (C 1 -C 4 alkylamino) carbonyl, (C 1 -C 4 - dialkylamino) carbonyl, Ci-C 4 alkylsulfinyl, C r C 4 alkylsulfonyl, C 3 -C 8 - cycloalkyl, 3- to 6-membered heterocyclyl with one to four fabric under Sauer ⁇ , sulfur, nitrogen and a group NR 6 selected heteroatoms, where
- C 3 -C 8 -cycloalkyl C 3 -C 8 -cycloalkenyl, 3- to 6-membered heterocyclyl having one to four heteroatoms selected from oxygen, sulfur, nitrogen and a group NR 6 , where R 6 is hydrogen, C r is C 6 alkyl, C 3 -C 6 alkenyl or C 3 -C 6 alkynyl;
- Cycloalkenyl, 3- to 6-membered heterocyclyl, phenyl and naphthyl can be teil ⁇ partially or fully halogenated and / or one to three substituents selected from the group cyano, nitro, Ci-C 4 alkyl, CrCrFiuoralkyl, C 1 -C 4 -alkoxy, (C r C 4 alkyl) amino, (CrC ⁇ ⁇ dialkyl amino, trifluoromethylsulfonyl, formyl, or phenoxy can gene; or
- R 4 and R 5 together form a saturated or partially unsaturated 5- to 6-membered nitrogen heterocycle having one or two carbonyl groups, thio-carbonyl groups and / or one or two further heteroatoms selected from O, S, N and a group NR 6 may have as ring members, wherein R 6 6 alkenyl or C 3 -C 6 -AIkinyl hydrogen, C r C 6 alkyl, C 3 -C, and which in turn substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy and or C 1 -C 4 - haloalkyl may be substituted.
- A is a group of the formula -NR 4 R 5 , in which the substituents R 4 and R 5 are independently of one another
- A is a group of the research mel -NR 4 R 5, in which the substituents R 4 and R 5 are independently hydrogen or C r C 6 alkyl.
- A is a Grup ⁇ pe of the formula -NR 4 R 5 wherein R 4 is hydrogen, C r C 6 alkyl, CRCE haloalkyl, C 2 -C 6 alkenyl or C 2 -C 6 -alkynyl, particularly preferably hydrogen or C 1 -C 6 -alkyl, very preferably C 1 -C 6 -alkyl, particularly preferably methyl; and
- R 5 CRQS alkyl, C r C 4 haloalkyl, C 3 -C 8 cycloalkyl or phenyl, particularly preferably C 1 -C 6 -alkyl, very preferably C r C 4 alkyl; mean.
- the process steps according to the invention can be operated both batchwise and continuously in reaction vessels suitable for this purpose.
- stirred tanks and stirred reactors are usually used. These are usually equipped to dissipate the heat of reaction with suitable heat exchangers or jacket cooling.
- the reaction steps according to the invention are also carried out continuously in the reactors customary for this purpose, for example in stirred kettles, stirred tank reactors, cascades and tubular reactors, wherein reactors are preferred with low backmixing.
- the amount of solvent or diluent is usually chosen so that the reaction mixtures remain fluid during the reaction.
- the 3-phenyl (thio) uracils and dithiouracils of the formula I are prepared by the reaction of a carbamate of the formula II with an enamine of the formula III:
- the X 1 variables X 2, X 3, R 1, R 2, R 3, and Ar and A have the obligations Bedeu ⁇ above, in particular the preferred meanings mentioned as being preferred Be ⁇ in the description.
- L 1 represents a nucleophilically displaceable leaving group, preferably C r C 6 alkoxy or C 1 -C 6 -alkylthio, particularly preferably C r C 6 -alkoxy.
- L 2 is a nucleophilically displaceable leaving group; preferably represents -C 6 -alkoxy, C r C 6 haloalkoxy, C r C 4 -alkoxy-C 2 -C 4 alkoxy,
- C 1 -C 4 -alkoxy and C r C 4 -alkylthio may be substituted; preferably C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 4 -alkoxy-C 2 -C 4 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -haloalkenyloxy, C 3 -C 6- alkynyloxy or C 3 -C 6 -haloalkynyloxy; very preferably C 1 -C 6 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C -alkoxy, C 2 -C 6 -alkenyloxy or C 3 -C 6 -alkynyloxy; exceptionally preferred for C 1 -C 6 -alkoxy.
- This reaction of the carbamates of the formula II with enamines of the formula III is usually carried out at temperatures above room temperature, for example from 25 ° C. to 200 ° C., preferably from 90 0 C to 19O 0 C, particularly preferably from 100 0 C to 14O 0 C in an inert organic solvent in the presence of a base (see. for example WO 99/31091).
- the reaction pressure is of secondary importance for the success of the process according to the invention and can be, for example, in the range from 500 mbar to 10 bar.
- the reaction will be in the range of normal pressure, i. in the range of 0.9 to 1, 2 bar performed.
- the reaction time required for the reaction is usually in the range of 1h to 24h, and especially in the range of 2h to 8h.
- the reaction can in principle be carried out in bulk. However, it is preferable to react the carbamates of the formula II with the enamines of the formula III in an organic solvent. Basically suitable are all solvents which are able to dissolve the carbamates of the formula II and the enamines of the formula III at least partially and preferably completely under reaction conditions. Preferred solvents are polar protic solvents.
- Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and mixtures of C 5 -C 8 alkanes, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as methylene chloride, chloroform and chlorobenzene, ethers such as Diethyl ether, diisopropyl ether, tert-butyl methyl ether, dioxane, diethylene glycol dimethyl ether, anisole and tetrahydrofuran, nitriles such as acetonitrile and propionitrile, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert-butanol, carboxylic esters such as butyl acetate, and dimethylsulfoxide, dimethylformamide, dimethylacetamide and
- the bases used are generally inorganic compounds such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal and alkaline earth metal hydrides such as lithium hydride, sodium hydride, Potassium hydride and calcium hydride, alkali metal amides, such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal carbonates, such as lithium carbonate, sodium carbonate, potassium carbonate, calcium carbonate and cesium carbonate, and also alkali metal bicarbonates, such as sodium bicarbonate, organometallic compounds, in particular alkali metal alkyls, such as methyllithium, butyllithium and Phenyllithium, alkali metal and alkaline earth metal alcoholates such as lithium methoxide, sodium methoxide, sodium ethanolate, potassium
- the bases are generally in excess, more preferably with 1.1 to 3 equivalents with respect to the carbamate of the forms! Il used, but they can also be used as a solvent. It may be advantageous to add the base offset over a period of time.
- the bases are preferably used with 1.1 to 2.4 equivalents, very preferably with 2.2 to 2.4 equivalents, more preferably with 2.3 equivalents, with respect to the carbamate II.
- the starting materials are generally reacted with one another in equimolar amounts. It may be advantageous to use one component in an excess based on the other component.
- the compounds in a molar ratio Il: III in the range of 1.5: 1 to 1: 1, 5, more preferably 1: 1 to 1: 1, 2, particularly preferably 1: 1 use.
- the compounds L 1 -H and L 2 -H formed during the reaction of the carbamates of the formula II with the enamines of the formula III will be partially removed from the reaction mixture during the reaction, in particular if the compounds L 1 - H and L 2 " H is a dC 4 -alkanol, such as methanol or ethanol, for this purpose, the reaction is carried out in a manner known per se at a temperature and a pressure at which the compounds L 1 -H and L 2 - If appropriate, the solvent is distilled off from the reaction mixture as an azeotrope and, if appropriate, fresh solvent is added to the reaction or the solvent distilled off with the compounds L 1 -H and L 2 -H is distilled off, if appropriate by distillation of the compounds L 1 -H and L 2 -H lead back into the reaction.
- the compounds L 1 - H and L 2 " H is a dC 4 -alkanol, such as methanol or ethanol
- the solvent used has a Her ⁇ detician of at least 10 0 C, particularly at least 30 0 C, above the boiling point of the compounds formed in the reaction L 1 and L 2 -H ⁇ having at Qeweils normal pressure).
- the reaction of the carbamates of the formula II with the enamines of the formula III is carried out in an apparatus which is provided with at least one distillation or rectification apparatus, for example a distillation column, which firstly distils off the compounds L 1 -H and L 2 -H, possibly together with Solvent allowed and at the same time a separation and recycling of the possibly with the compounds L 1 -H and L 2 -H distilled off solvent allows.
- at least one distillation or rectification apparatus for example a distillation column
- the compounds II and III can be brought into contact with one another in any desired manner, that is to say the reactants and the base can be separated, introduced into the reaction vessel simultaneously or successively and led to reaction.
- the main amount, more particularly at least 80% and particularly preferably the total amount or almost the total amount (> 95%) of the carbamates of the formula II is added during the course of the reaction, e.g. over a period of 0.5 to 20 h and in particular 1 to 10 h, the main amount, in particular at least 80% and particularly preferably the total amount or almost the total amount (> 95%) of the enamine of the formula III under reaction conditions.
- the enamines of the formula III are preferably dissolved in a solvent.
- the compounds II and III are initially charged and then the main amount, in particular at least 80% and particularly preferably the total amount or almost the total amount (> 95%) of the base is added.
- the reaction may optionally be completed by post-dosing of base.
- the isolation of the 3-phenyl (thio) uracils and dithiouracils of the formula I from the reaction mixture can be carried out in a manner known per se. If the reaction has been carried out in a solvent, the reaction mixture will generally be concentrated and / or cooled and / or a precipitant added. Suitable precipitants are solvents in which the 3-phenyl- (thio) uracils and -dithiouracils of the formula I, at least at temperatures below 25 ° C not or only to a small extent dissolves.
- aliphatic and cycloaliphatic hydrocarbons such as pentane, hexane, cyclohexane, heptane, petroleum ether, toluene and the like.
- the precipitation / crystallization may be followed by further purification measures. If the reaction is carried out as preferably in an alcohol, in particular in methanol or ethanol, or in an alkylbenzene, it is generally not necessary to add a precipitant.
- the pH of the reaction mixture is ⁇ 7 set.
- inorganic acids such as, for example, hydrochloric acid or sulfuric acid.
- R b and R d are hydrogen
- R b and R d are hydrogen
- L 1 is a nucleophilically displaceable leaving group, preferably C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, more preferably C 1 -C 6 -alkoxy, particularly preferably C 1 -C 4 -alkoxy, very preferably methoxy or ethoxy;
- L 2 is a nucleophilically displaceable leaving group; preferred alkoxy is C 6 alkoxy, C r C 6 haloalkoxy, C 1 -C 4 -alkoxy-C 2 -C 4 -BIkOXy, -C 4 -alkylthio-C 2 C 4, C 2 -C 6 - Al kenyloxy, C 2 -C 6 -haloalkenyloxy, C 3 -C 6 -alkynyloxy, C 3 -C 6 -haloalkynyloxy, C 3 -C 8 -cycloalkyloxy, C 1 -C 6 -cyanoalkoxy or benzyloxy, which in turn is attached to the phenyl ring may be partially or fully halogenated and / or by one to three radicals from the group cyano, nitro, C r C 4 alkyl, C 1 -C 4 -alkoxy and Ci-C 4 alkylthio may be substituted
- R 1 is hydrogen, C r C 6 alkyl, C r C 4 cyanoalkyl, C ⁇ C 6 haloalkyl, C 3 -C 8 - cycloalkyl, C 2 -C 6 -alkenyl -alkyl, C 2 -C 6 haloalkenyl, C 3 -C 6 alkynyl, C 3 -C 6 haloalkynyl or phenyl-C 1 -C 4 alkyl; very preferably hydrogen or C 1 -C 4 -A ⁇ yI 1 is particularly preferably hydrogen, methyl or ethyl, especially preferably methyl;
- R 2 is hydrogen, C 1 -C 4 -AIRyI or CrOrHalogenalRyl, particularly preferably hydrogen, methyl, difluoromethyl or trifluoromethyl, particularly preferably trifluoromethyl;
- R 3 is hydrogen or C 1 -C 4 -alkyl, particularly preferably hydrogen.
- R a is hydrogen, halogen or cyano, particularly preferably hydrogen, fluorine, chlorine or cyano, very preferably hydrogen, chlorine or cyano, very preferably hydrogen or chlorine, very particularly preferably hydrogen;
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R 4 and R 5 independently of one another are hydrogen or C 1 -C 6 -alkyl, which in turn is selected from the group by a substituent
- R 4 is hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -arrenyl or C 2 -C 6 -ARinyl, very preferably hydrogen or C 1 -C 6 -alkyl, particularly preferably C 1 -C 4 -alkyl, most preferably methyl;
- R 5 is C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl or phenyl, very preferably C 1 -C 6 -alkyl, particularly preferably C 1 -C 4 -alkyl.
- R 1 is C 1 -C 6 -alkyl, Ci-C 4 cyanoalkyl, CRCE haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 - alkenyl, C 2 -C 6 haloalkenyl, C 3 -C 6 -alkynyl, C 3 -C 6 haloalkynyl, phenyl-C r C 4 alkyl or amino; is prepared by adding carbamates of the formula II
- R 1 is hydrogen
- the variables X 2 , R 2 and R 3 have the abovementioned Be ⁇ meanings and L 2 is a nucleophilically displaceable leaving group, are reacted;
- R 1 -L 4 VI in which R 1 is C 1 -C 6 -alkyl, -C 4 cyanoalkyl, C r -haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 -Haloalkenyl, C 3 -C 6 -alkynyl, C 3 -C 6 -
- aminating agent of the formula VII H 2 NL 5 VII, wherein L 5 is a nucleophilically displaceable leaving group
- L 4 is in the alkylating agent of formula VI is a nucleophilically displaceable group for Abgangs ⁇ , preferably halogen, hydrogensulfate, C r C 6 -AlkyIsulfat, sulfate, C 1 -C 6 - alkylsulfonyloxy, CrC 6 -HalogenalkyIsulfonyIoxy or phenylsulfonyloxy, wherein the phenyl ring optionally with halogen, nitro, C 1 -C 6 alkyl or
- C 1 -C 6 -haloalkyl is monosubstituted or polysubstituted, particularly preferably halogen, hydrogensulfate, C 1 -C 6 -alkylsulfonyloxy, C 1 -C 6 -haloalkylsulfonyloxy, phenylsulfonyloxy, p-toluenesulfonyloxy, p-chlorophenylsulfonyloxy, p-bromophenylsulfonyloxy, or p-nitrophenylsulfonyloxy, especially preferred Chloro, methylsulfonyloxy, trifluoromethylsulfonyloxy or
- L 5 represents the aminating agent of the formula VII gear group is a nucleophilically displaceable Ab ⁇ , preferably halogen, hydrogensulfate, Ci-C 6 alkylsulfonyloxy, C 1 -C 6 -
- Preferred alkylating agents are C 1 -C 4 alkyl halides, di-C 1 -C 4 alkyl sulphates, Phe nylsulfonklare-Ci-C 4 -alkyl, where the phenyl radical may optionally be mono- or substituted with halogen, nitro or C 6 -AlkyI disubstituted is.
- alkylating agents are methylating agents or ethylating agents such as dimethyl sulfate, diethyl sulfate, methyl iodide, ethyl iodide, methyl bromide, methyl chloride, ethyl bromide, ethyl chloride, C 1 -C 6 -alkyl sulfonic acid methyl ester or ethyl ester or the methyl or ethyl esters of the abovementioned phenylsulfonic acids.
- An especially preferred methylating agent is dimethylsulfate.
- the alkylating agent can be used both in an equimolar amount, based on the compound I, and in a substoichiometric amount or in a superstoichiometric amount.
- at least an equimolar amount of alkylating agent VI, based on the compound I is used.
- Suitable bases are in principle all compounds which are capable of deprotonating the lactam nitrogen atom.
- Suitable bases are, for example, the bases mentioned in connection with the preparation of compound I by reacting II with III.
- the base is preferably selected from alkali metal and alkaline earth metal hydroxides such as sodium hydroxide, potassium hydroxide and lithium hydroxide, alkali metal and alkaline earth metal oxides such as calcium oxide, alkali metal and alkaline earth metal carbonates such as lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate, magnesium carbonate, calcium carbonate, zinc carbonate or barium carbonate.
- the base used is sodium hydroxide or potassium carbonate.
- the base can be used in substoichiometric, superstoichiometric or equimolar amounts, based on the compound I. At least one equimolar amount of base, based on the compound I, is preferably used.
- the amount of base will generally be not more than 1.3 mol, based on 1 mol of the compound I.
- Suitable solvents for these reactions are aliphatic, cycloaliphatic or aromatic hydrocarbons, such as pentane, hexane, cyclopentane, cyclohexane, toluene, xylene, chlorinated aliphatic and aromatic hydrocarbons, such as dichloromethane, trichloromethane, 1,2-dichloroethane , 1,1,2,2-tetrachloroethane, chlorobenzene, 1, 2-, 1,3- or 1,4-dichlorobenzene, chlorotoluenes, dichlorotoluenes, open-chain dialkyl ethers such as diethyl ether, di-n-propyl ether, di-n- isopropyl ether, methyl tert-butyl ether,
- the alkylation of the compound I at temperatures between -5 0 C and 100 0 C, preferably at temperatures between 0 0 C and 80 0 C and ins ⁇ particular at temperatures between 20 0 C and 50 0 C by.
- the reaction time can be determined by the skilled worker in a conventional manner by routine methods such as thin-layer chromatography or HPLC.
- the reaction can also be carried out in an aqueous multiphase system, preferably in the presence of phase transfer catalysts such as quaternary ammonium salts or phosphonium salts.
- Suitable quaternary ammonium salts include tetraalkyl (C r C 18 ) ammonium chlorides, bromides, fluorides or tetrafluoroborates such as tetraethylammonium chloride, tetrabutylammonium bromide, tetrabutylammonium iodide, tetrabutylammonium tetrafluoroborate, N-benzyltrialkyl- (C 1 -C 18 ) -ammonium chlorides, bromides or fluorides such as benzyltriethylammonium chloride, preferably tetrabutylammonium bromide or tetrabutylammonium iodide.
- Suitable phosphonium salts are, for example, tetraphenylphosphonium chloride or bromide, tetraalkyl (C r C 18 ) phosphonium chloride or bromide such as tetrabutylphosphonium bromide.
- the multiphase system comprises an aqueous phase and at least one organic liquid phase.
- solid phases can also occur during the course of the reaction.
- the aqueous phase is preferably a solution of alkali metal or alkaline earth metal hydroxides or carbonates in water.
- suitable alkali metal or alkaline earth metal hydroxides or carbonates reference is made to what has been said above. Particular preference is given to using alkali metal or alkaline earth metal hydroxides, especially sodium hydroxide.
- the multiphase system consists of aqueous sodium hydroxide solution as the aqueous phase and of toluene and tetrahydrofuran or dichloromethane and tetrahydrofuran as the organic phase.
- the compound I in one of the aforementioned organic solvents or solvent mixtures submit. Thereafter, the aqueous solution of the base, the alkylating agent VI and the phase transfer catalyst with mixing and then brings in genann ⁇ ten temperature range, the reaction to an end.
- the reaction can be carried out at atmospheric pressure, reduced pressure or under elevated pressure, optionally under inert gas, continuously or batchwise.
- R b and R d are hydrogen
- R 1 is hydrogen; and X 2 is oxygen,
- R 1 - L 4 VI in which R 1 is C 1 -C 6 -alkyl, -C 4 cyanoalkyl, Ci-C 6 haloalkyl, C 3 -C 8 -
- Cycloalkyl C 2 -C 6 alkenyl, C 2 -C 6 -haloalkenyl, C 3 -C 6 -alkynyl, C 3 -C 6 -haloalkynyl or phenyl-Ci-C 4 -alkyl, and L 4 is a nucleophilic displaceable Leaving group, preferably the above-mentioned as preferred means;
- R 1 is C 1 -C 6 -AIRyI, C ⁇ C 4 cyanoalkyl, C r C 6 haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 alkenyl, C 2 - C 6 haloalkenyl, C 3 -C 6 alkynyl, C 3 -C 6 haloalkynyl or phenylCrC 4 alkyl; and R b and R d are hydrogen;
- L 1 is a nucleophilically displaceable leaving group, C 1 -C 6 -alkoxy or Ci-C 6 alkylthio preferred, particularly preferably C 1 -C 6 -alkoxy, particularly preferably C r C 4 alkoxy, very preferably methoxy or ethoxy;
- L 2 is a nucleophilically displaceable leaving group; preferably C 1 -C 6 -alkoxy, -C 6 haloalkoxy, C 1 -C 4 -alkoxy-C 2 -C 4 -BIkOXy,
- C r C 4 alkoxy and C 1 -C 4 alkylthio may be substituted; preferably C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 4 -alkoxy-C 2 -C 4 -alkoxy, C 2 -C 6 -alkenyloxy, C 2 -C 6 -haloalkenyloxy, C 3 -C 6 alkynyloxy or
- C 3 -C 6 haloalkynyloxy very preferably C r C 6 alkoxy, C r C 4 -alkoxy-C 2 -C 4 alkoxy, C 2 -C 6 alkenyloxy or C 3 -C 6 alkynyloxy; most preferred for C r C 6 alkoxy.
- R 1 is C 1 -C 6 -alkyl, C r C 4 cyanoalkyl, C r C 6 haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 - alkenyl, C 2 -C 6 haloalkenyl, C 3 C 6 -alkynyl, C 3 -C 6 -haloalkynyl or phenyl-
- CrC 4 -alkyl very preferably C 1 -C 4 -alkyl, particularly preferably methyl or ethyl, especially preferably methyl;
- R 2 is hydrogen, C r C 4 alkyl or Ci-C 4 haloalkyl, more preferably hydrogen, methyl, difluoromethyl or trifluoromethyl, most preferably trifluoromethyl;
- R 3 is hydrogen or C 1 -C 4 -alkyl, particularly preferably hydrogen.
- R a is hydrogen, halogen or cyano, particularly preferably hydrogen, fluorine, chlorine or cyano, very preferably hydrogen, chlorine or cyano, very preferably hydrogen or chlorine, very particularly preferably hydrogen;
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R 4 and R 5 independently of one another are hydrogen or C 1 -C 6 -alkyl, which in turn is selected from the group by a substituent
- Halogen, cyano and C 1 -C 4 -alkoxy, preferably halogen, may be substituted;
- R 4 is hydrogen, C r C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 -AIkinyl, very preferably hydrogen or C-
- R 5 is C 1 -C 6 -alkyl, C 3 -C 8 -cycloalkyl or phenyl, very preferably C 1 -C 6 -alkyl, particularly preferably C 1 -C 4 -alkyl.
- Suitable aminating agents of the formula VII are, for example, 1-aminooxy-2,4-dinitrobenzene or O-mesitylenesulfonylhydroxylamine.
- Suitable bases are all customary inorganic or organic bases. Suitable bases are, for example, the bases mentioned in connection with the preparation of compound I by reaction of II with III.
- Preferred bases are alkali metal alcoholates, in particular lithium, sodium or potassium alkoxides, such as sodium methylate, sodium methoxide, lithium ethylate, potassium methoxide, potassium ethylate, potassium tert-butoxide, sodium tert-butoxide, sodium isopropylate, potassium tert-pentylate
- Alkali metal hydrides such as Natri ⁇ umhydrid, potassium hydride, alkali metal carbonates such as lithium carbonate, sodium carbonate, potassium carbonate, cesium carbonate or tertiary amines, in particular amidine bases such as 1, 8-diazabicyclo [5.4.0] undec-7-ene.
- Preferred solvents for this purpose are nitriles such as acetonitrile, propionitrile or butyronitrile, ketones such as acetone and methyl ethyl ketone, carbonates such as dimethyl carbonate, diethyl carbonate and ethylene carbonate and amides such as N, N-dimethylformamide, N, N-dimethylacetamide and N-methylpyrrolidone.
- organic solvents with a basic character for. B. the aforementioned tertiary amines such as trialkylamines and pyridine compounds.
- the reaction at temperatures from 0 to 80 0 C preferably between 10 and 60 0 C perform.
- the workup of the reaction mixture to obtain the target product I can be carried out according to customary methods.
- the solvent used by conventional methods for example by distillation, remove. It is then possible to take up the target compound I in a water-immiscible organic solvent, extract any impurities with optionally acidified water, dry and remove the solvent under reduced pressure.
- the usual methods such as crystallization, precipitation or chromatography can be used.
- When using a two-phase system will usually work up extractive.
- Compounds of formula I wherein one of X 1, X 2 or X 3 or the radicals X 1, X 2 and X 3 each represent oxygen can be prepared by known methods thy by Behan- with sulfurizing agents in compounds of general formula I converted in which one of the radicals X 1 , X 2 or X 3 or the radicals X 1 , X 2 and X 3 are each sulfur.
- suitable sulfurizing agents are organophosphorus sulfides such as the Lawesson reagent, organotin sulfides or phosphorus (V) sulfides (see also J. March, Advanced Organic Synthesis, 2nd Edition, Wiley Interscience 1985, p. 794 and literature cited therein).
- the reaction can be carried out in a solvent or in substance. Suitable solvents are the above-mentioned inert solvents and basic solvents such as pyridine and the like.
- L 3 is a nucleophilically displaceable leaving group, preferably chlorine or C 1 -C 6 -alkoxy; especially preferred for chlorine.
- the reaction of the amines of the formula IV is carried out with compounds of formula V Usually, for chhold at temperatures from -10 0 C to 160 0 C, preferably O 0 C to 13O 0 C, very preferably from 25 0 C to 130 0 C, in an inert organic solvents in if appropriate in the presence of a base (eg Houben-Weyl, Methods of Organic Chemistry, E5, 1985, pp. 972-980, as well as VIII, pp. 655 and Xl Part 2, p.
- a base eg Houben-Weyl, Methods of Organic Chemistry, E5, 1985, pp. 972-980, as well as VIII, pp. 655 and Xl Part 2, p.
- the reaction pressure is of secondary importance for the success of the process according to the invention and can be, for example, in the range from 500 mbar to 10 bar.
- the reaction will be in the range of normal pressure, i. in the range of 0.9 to 1, 2 bar performed.
- the reaction time required for the reaction is usually in the range of 1 h to 24 h, and in particular in the range of 2h to 8h.
- reaction can in principle be carried out in bulk.
- the amines of the formula IV are preferably reacted with the compounds of the formula V in an organic solvent.
- suitable are all solvents which are able to dissolve the compounds IV and V at least partially and preferably completely under reaction conditions.
- Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and mixtures of C 5 -C 8 alkanes, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as methylene chloride, chloroform and chlorobenzene, ethers such as Diethyl ether, diisopropyl ether, tert-butyimethyl ether, dioxane, anisole and tetrahydrofuran, carboxylic acid esters such as butyl acetate, particularly preferably halogenated hydrocarbons and ethers.
- aromatic hydrocarbons such as toluene, o-, m- and p-xylene
- halogenated hydrocarbons such as methylene chloride, chloroform and chlorobenzene
- ethers such as Diethyl ether, diisopropyl
- reaction of the amines of the formula IV with compounds of the formula V can be carried out in the presence of a base, but the use of a base is not necessary.
- the bases used are generally inorganic compounds such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide.
- the bases are generally employed in equimolar amounts, but they can also be used catalytically, in excess or, if appropriate, as solvent.
- reaction of the amines of the formula IV with compounds of the formula V is carried out in the absence of a base.
- This preferred variant of the reaction provides u.a. the advantages that elaborate workup is omitted after the end of the reaction and the further implementation of the carbamate II thus prepared to 3-phenyl (thio) uracils and -dithiouracilen I, preferably 3-phenyluracils IA1, wherein also optionally the aforementioned Chlo ⁇ tion of the carbamate II can be carried out, can take place as a one-pot reaction or requires only a solvent exchange.
- the starting materials are generally reacted with one another in equimolar amounts. It may be advantageous to use V in an excess relative to IV. Preferably, the compounds will be used in a molar ratio IV: V in the range from 1.6: 1 to 1: 1, 6, in particular 1: 1, 4 to 1: 1.
- the compound L 3 -H formed in the reaction of the amines of the formula IV with the compounds of the formula V is preferably removed from the reaction mixture by at least 80% during the reaction, in particular when the compound L 3 -H is involved a CrC 4 alkanol such as methanol or ethanol.
- the reaction is carried out in a conventional manner at a temperature and a pressure at which the compound L 3 -H optionally distilled off as an azeotrope with the solvent from the reaction mixture. If appropriate, fresh solvent is introduced into the reaction for the purpose of equilibration, or the solvent distilled off with the compound L 3 -H is recycled to the reaction after optionally depleting the amount of the compound L 3 -Hrn by distillation.
- the solvent used has a Her ⁇ detician of at least 10 0 C and in particular at least 30 0 C above the Her ⁇ deissers the compound L formed in the reaction 3 -H comprises (each at Nor ⁇ maldruck) .
- the reaction of the amines of the formula IV with the compounds of the formula V is carried out in an apparatus which is provided with at least one distillation and rectification apparatus, for example a distillation column, which firstly distils off the compound L 3 . H, if appropriate, together with solvent allowed and at the same time allows separation and recycling of the optionally distilled off with the compound L 3 -H solvent.
- the amines of the formula IV can be brought into contact with the compounds of the formula V and, if appropriate, the base in any desired manner, ie the reactants and, if appropriate, the base can be introduced into the reaction vessel separately or simultaneously be led to the reaction.
- the amine IV is initially introduced, and then optionally the base and then the compound V are added.
- the main amount, in particular at least 80% and particularly preferably the total amount or almost the total amount (> 95%) of the amines of the formula IV is added during the course of the reaction, e.g. over a period of 0.5 to 20 h and especially 1 to 10 h, the main amount, in particular at least 80% and particularly preferably the total amount or almost the total amount (> 95%) of the compounds of the formula V under reaction conditions.
- the compounds of the formula V are preferably dissolved in a solvent.
- a certain amount of time e.g. 1 h to 10 h, in particular 2 h to 5 h, allowed to react.
- R b and R d are hydrogen
- L 3 is a nucleophilically displaceable leaving group, preferably chlorine or C 1 -C 6 -alkoxy; especially preferred for chlorine.
- L 1 , R a , R c and R 4 and R 5 are each alone or in combination have the following meanings: L 1 nucleophilically displaceable leaving group, preferably C 1 -C 6 -alkoxy or Ci-C 6 alkylthio, particularly preferably C 1 -C 6 -alkoxy, particularly preferably C 1 -C 4 -alkoxy, very preferably methoxy or ethoxy;
- R a is hydrogen, halogen or cyano, particularly preferably hydrogen, fluorine, chlorine or cyano, very preferably hydrogen, chlorine or cyano, very preferably hydrogen or chlorine, very particularly preferably hydrogen;
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R 4 and R 5 are independent of each other
- Halogen, cyano and C 1 -C 4 -alkoxy, preferably halogen, may be substituted;
- R 4 is hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -arrenyl or C 2 -C 6 -alkynyl, very preferably hydrogen or C 1 -C 6 -alkyl, particularly preferably C 1 -C 4 - AIRyI, most preferably methyl; and
- R 5 is C r C 6 alkyl, C 3 -C 8 cycloalkyl or phenyl, very preferably C 1 -C 6 -AIk ⁇ , more preferably C 1 -C 4 -AIRyI.
- the amines of the formula IV required for the preparation of the carbamates of the formula II are known in the literature (for example WO 04/039768) or can be prepared according to the cited literature.
- the compounds of the formula V required for the preparation of the carbamates of the formula II are known in the literature (eg Houben-Weyl, Methods of Organic Chemistry, E4, 1983, pp. 6-17) and can be purchased or be prepared according to the cited literature.
- the carbamates of the formula II prepared in this way can then, if desired, be halogenated in an intermediate step before the reaction with the enamines of formula III at the radical Ar.
- the carbamates of the formula II prepared in this way can be chlorinated or brominated in a further step on the radical Ar, very preferably chlorinated.
- the halogenation is usually carried out at temperatures of 0 0 C to 100 0 C., preferably 20 0 C to 70 0 C, in an inert organic solvent optionally in the presence of a catalyst (eg. B. Buehler, Peason, Survey of Organic Synthesis, Interscience Publishers 1970, p. 392-404).
- a catalyst eg. B. Buehler, Peason, Survey of Organic Synthesis, Interscience Publishers 1970, p. 392-404.
- the reaction pressure is of subordinate importance for the success of the process according to the invention and can be, for example, in the range from 500 mbar to 10 bar.
- the reaction will be in the range of normal pressure, i. in the range of 0.9 to 1, 2 bar performed.
- the reaction time required for the reaction is usually in the range of 1 h to 24 h, and in particular in the range of 3h to 12h.
- the reaction can in principle be carried out in bulk. However, it is preferable to react the carbamates of the formula V with the halogenating agent in an organic solvent. In principle, all solvents are suitable which are able to dissolve the compound V at least partially and preferably completely under reaction conditions.
- Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and mixtures of C 5 -C 8 alkanes, halogenated hydrocarbons such as methylene chloride, chloroform, butyl chloride and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, tert-butyl methyl ether, dioxane, anisole and Tetrahydrofuran, nitriles such as acetonitrile and propionitrile, ketones such as acetone, methyl ethyl ketone, diethyl ketone and tert-butyl methyl ketone, carboxylic acids such as formic acid or acetic acid, esters such as butyl acetate or dimethyl carbonate, and sulfuryl chloride, particularly preferably halogenated hydrocarbons and sulfuryl chloride.
- halogenated hydrocarbons such as m
- halogenating agents required for halogenation are known in the literature (eg Buehler, Peason, Survey of Organic Synthesis, Interscience Publishers 1970, pp. 392-404) or can be prepared according to the cited literature.
- suitable halogenating agents are chlorine, N-chlorosuccinimide, SO 2 Cl 2 , HCl / H 2 O 2 , 1, 3-dichloro-5,5-dimethylhydanthoin, bromine, N-bromosuccinimide, HBr / H 2 O 2 or 1,3 Dibromo-5,5-dimethylhydanthoin use.
- the halogenation of the carbamates of the formula II can be carried out in the presence of a catalyst, depending on the halogenating agent chosen.
- a catalyst e.g. Lewis acids such as boron trifluoride, aluminum trichloride, iron-lll-chloride, tin-IV-chloride, titanium-IV-chloride and zinc-ll-chloride use.
- the halogenating agent is generally used equimolar, but it can also be used in excess, in excess or optionally as a solvent.
- L 1 nucleophilically displaceable leaving group, preferably C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, particularly preferably C 1 -C 6 -alkoxy, particularly preferably C 1 -C 4 -alkoxy, very preferably methoxy or ethoxy;
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R 4 and R 5 are independent of each other
- Halogen, cyano and C 1 -C 4 -alkoxy, preferably halogen, may be substituted;
- R 4 is hydrogen, C r C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl, very preferably hydrogen or Ci-Ce alkyl, particularly preferably C 1 -C 4 -AIRyI extraordinarily preferably methyl; and R 5 d-C ⁇ -alkyl, C 3 -C 8 -cycloalkyl or phenyl, very preferably C 6 -alkyl, particularly preferably C r C 4 alkyl.
- a further preferred embodiment therefore relates to a process in which the amines of the formula IV are reacted with compounds of the formula V to form bamates of the formula II in a first step, and then the carbamates of the formula II without isolation with the enamines of the formula III to 3-phenyl (thio) uracils and - dithiouracils of the formula I.
- the reaction of the carbamates of the formula II with the enamines of the formula III will be carried out in the solvent used to prepare the carbamate of the formula II.
- a further embodiment of the method according to the invention can 3- phenyluracils of formula IA1, wherein R 1 is C 1 -C 6 -alkyl, CrC ⁇ cyanoalkyl, Ci-C 6 - haloalkyl, C 3 -C 8 cycloalkyl, C 2 -C 6 Alkenyl, C 2 -C 6 -haloalkenyl, C 3 -C 6 -alkynyl, C 3 - C 6 -haloalkynyl or PhOnYl-C 1 -C 4 -BlkYl; and R b and R d are hydrogen; are prepared by reacting corresponding amines of the formula IV.
- the inventive method allows for the first time the production of carbamates of the formula II
- L 1 is a nucleophilically displaceable leaving group, preferably C 1 -C 6 -alkoxy or C 1 -C 6 -alkylthio, particularly preferably C 1 -C 6 -alkoxy ,
- L 1 nucleophilically displaceable leaving group preferably C 1 -C 6 -alkoxy or CrC 6 alkylthio, particularly preferably Ci-C 6 -alkoxy, particularly preferably C r C 4 alkoxy, very preferably methoxy or ethoxy;
- R a is hydrogen, halogen or cyano, particularly preferably hydrogen, fluorine, chlorine or cyano, very preferably hydrogen, chlorine or cyano, very preferably hydrogen or chlorine;
- R b is hydrogen
- R c is hydrogen or halogen, particularly preferably hydrogen, fluorine or chlorine, very preferably hydrogen or fluorine, very preferably fluorine;
- R d is hydrogen;
- R 4 and R 5 are independent of each other
- Halogen, cyano and C 1 -C 4 -alkoxy, preferably halogen, may be substituted;
- R 4 is hydrogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl or C 2 -C 6 -alkynyl, very preferably hydrogen or C 1 -C 6 -alkyl, more preferably C 1 -C 4 -alkyl, very preferably methyl;
- R 5 is d-Ce-alkyl, C 3 -C 8 -cycloalkyl or phenyl, very preferably C 1 -C 6 -alkyl, particularly preferably C 1 -C 4 -alkyl.
- the carbamates of the formula II.AIb in particular the compounds of the formula II.AIb1 to II.A.1.b.6O, which differ from the corresponding compounds of the formula II.A.1.a .1 to II.A.1.a.6O differ in that L 1 is ethoxy.
- the carbamates of the formula MA1.C in particular the compounds of the formula II.A.1.C.1 to II.A.1.C.60, which are different from the corresponding compounds of the formula II .A.la.1 to II.A.1.a.6O differ in that L 1 is n-propyloxy.
- the carbamates of the formula HALi in particular the compounds of the formula IIALi.1 to IIALi.60, which differ from the corresponding the compounds of formula II.A.la.1 to II.A.1.a.6O differ in that L 1 is ethylthio.
- Example 1.1.f To a solution of 300.0 g (0.897 mol) N- (4-fluoro-3-amino-benzoyl) -N '- / so-propyl-N I - methyisulfamid in chlorobenzene at 115-125 ° C. C. 134.7 g (1.22 mol) of ethyl chloroformate were added in portions and then stirred at 125.degree. C. for 2 h. Thereafter, the solvent and excess ethyl chloroformate were removed. This gave 312.8 g (96% of theory) of the title compound.
- Example 2.1 a 150 g (0.407 mol) of N- (3 - [(ethoxycarbonyl) amino] -4-fluoro-benzoyl) -N'-isopropyl-N'-methylsulfamide suspended in chlorobenzene were dissolved in a reaction vessel under Va ⁇ concentrated (internal temperature ⁇ 100 0 C). Then the vacuum gebro ⁇ surfaces and the suspension was cooled to 65 0 C. Subsequently, 760 g (5.517 mol) of sulfuryl chloride was added portionwise keeping the temperature at 50 ° C. The mixture was then stirred for 16 h.
- Example 3.1 a 9.13 g (0.049 mol) of ethyl 3-amino-4,4,4-trifluoro-2-butenoate were initially charged in DMF at room temperature. 12.84 g (0.059 mol) of potassium methylate solution (32% strength in methanol) were added and the mixture was stirred for a further 30 minutes. Subsequently, 20 g (0.049 mol) of N- (2-chloro-4-fluoro-5 - [(ethoxycarbonyl) amino] benzoyl) -N '- / so-propyl-N'- methylsulfamide added. The reaction mixture was heated and distilled off as much alcohol until 119 0 C were reached.
- reaction mixture was added dropwise to dilute hydrochloric acid while cooling, the pH being ⁇ 2 at the end.
- the precipitated product was filtered off, washed and dried. This gave 2.3 g (73% of theory) of the title compound.
- the aqueous phase was separated off and the organic phase was concentrated to dryness under reduced pressure.
- the chromatographic purification on silica gel was carried out in the manner described in Example 5 to give 4 fractions. After removal of the solvent, the first fraction contained 0.54 g of a mixture which consisted of 90% of the desired desired product of 1 H-MNR and the second fraction 2 contained 2.4 g of the desired product with a purity of> 95 % (Yield based on both fractions: 56%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0513453-6A BRPI0513453B1 (pt) | 2004-07-22 | 2005-07-13 | Processo para a preparação de compostos, e composto |
KR1020077004099A KR101238470B1 (ko) | 2004-07-22 | 2005-07-13 | 3-페닐(티오)우라실 및 디티오우라실의 제조 방법 |
US11/631,972 US8252925B2 (en) | 2004-07-22 | 2005-07-13 | Method for the production of 3-phenyl(thio)uracils and dithiouracils |
SI200531847T SI1773787T1 (sl) | 2004-07-22 | 2005-07-13 | Postopek za pripravo 3-fenil(tio)uracilov in ditiouracilov |
EP05763570.8A EP1773787B1 (de) | 2004-07-22 | 2005-07-13 | Verfahren zur herstellung von 3-phenyl(thio)uracilen und - dithiouracilen |
MX2007000067A MX2007000067A (es) | 2004-07-22 | 2005-07-13 | Procedimiento para preparar 3-fenil (tio) uracilos y - ditiouracilos. |
JP2007521854A JP4860613B2 (ja) | 2004-07-22 | 2005-07-13 | 3−フェニル(チオ)ウラシル類およびジチオウラシル類を製造する方法 |
UAA200701779A UA83764C2 (ru) | 2004-07-22 | 2005-07-13 | Способ получения 3-фенилурацилов и карбамат, примененный в способе |
DK05763570.8T DK1773787T3 (da) | 2004-07-22 | 2005-07-13 | Fremgangsmåde til fremstilling af 3-phenyl(thio)uraciler og -dithiouraciler |
ES05763570.8T ES2465499T3 (es) | 2004-07-22 | 2005-07-13 | Procedimiento para la preparación de 3-fenil(tio)uracilos y -ditiouracilos |
AU2005266622A AU2005266622B8 (en) | 2004-07-22 | 2005-07-13 | Method for the production of 3-phenyl(thio)uracils and dithiouracils |
EA200700289A EA012035B1 (ru) | 2004-07-22 | 2005-07-13 | Способ получения 3-фенилурацилов |
CN200580024680XA CN1989111B (zh) | 2004-07-22 | 2005-07-13 | 生产3-苯基(硫代)尿嘧啶和二硫代尿嘧啶的方法 |
CA2574406A CA2574406C (en) | 2004-07-22 | 2005-07-13 | Method for the production of 3-phenyl(thio)uracils and dithiouracils |
PL05763570T PL1773787T3 (pl) | 2004-07-22 | 2005-07-13 | Sposób wytwarzania 3-fenylo(tio)uracyli i 3-fenyloditiouracyli |
IL180180A IL180180A (en) | 2004-07-22 | 2006-12-19 | Process and intermediate for the production of 3-phenyl (thio)uracils and dithiouracils |
US13/040,292 US8124818B2 (en) | 2004-07-22 | 2011-03-04 | Method for the production of 3-phenyl(thio) uracils and dithiouracils |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004035656 | 2004-07-22 | ||
DE102004035656.4 | 2004-07-22 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/631,972 A-371-Of-International US8252925B2 (en) | 2004-07-22 | 2005-07-13 | Method for the production of 3-phenyl(thio)uracils and dithiouracils |
US13/040,292 Division US8124818B2 (en) | 2004-07-22 | 2011-03-04 | Method for the production of 3-phenyl(thio) uracils and dithiouracils |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006010474A1 true WO2006010474A1 (de) | 2006-02-02 |
Family
ID=34972926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/007577 WO2006010474A1 (de) | 2004-07-22 | 2005-07-13 | Verfahren zur herstellung von 3-phenyl(thio)uracilen und - dithiouracilen |
Country Status (19)
Country | Link |
---|---|
US (2) | US8252925B2 (de) |
EP (1) | EP1773787B1 (de) |
JP (2) | JP4860613B2 (de) |
KR (1) | KR101238470B1 (de) |
CN (1) | CN1989111B (de) |
AR (1) | AR050005A1 (de) |
AU (1) | AU2005266622B8 (de) |
BR (1) | BRPI0513453B1 (de) |
CA (1) | CA2574406C (de) |
DK (1) | DK1773787T3 (de) |
EA (1) | EA012035B1 (de) |
ES (1) | ES2465499T3 (de) |
IL (1) | IL180180A (de) |
MX (1) | MX2007000067A (de) |
PL (1) | PL1773787T3 (de) |
SI (1) | SI1773787T1 (de) |
UA (1) | UA83764C2 (de) |
WO (1) | WO2006010474A1 (de) |
ZA (1) | ZA200701464B (de) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008043836A1 (de) * | 2006-10-13 | 2008-04-17 | Basf Se | Hydrate des 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamids |
WO2008043835A2 (de) * | 2006-10-13 | 2008-04-17 | Basf Se | Kristalline form von 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamid |
WO2009050120A1 (de) * | 2007-10-12 | 2009-04-23 | Basf Se | Verfahren zur herstelung von sulfonsäurediamiden |
US8263806B2 (en) | 2005-12-01 | 2012-09-11 | Basf Se | Method for producing sulfonamides |
CN103130727A (zh) * | 2013-02-27 | 2013-06-05 | 江苏省农用激素工程技术研究中心有限公司 | 苯嘧磺草胺中间体的制备方法 |
WO2023017518A1 (en) | 2021-08-09 | 2023-02-16 | Adama Agan Ltd. | A new process of saflufenacil production using novel intermediates |
WO2023198484A1 (en) | 2022-04-12 | 2023-10-19 | BASF Agro B.V. | Improved process for recovering n,n-dimethylformamide (dmf) from an aqueous process stream |
EP4306508A1 (de) | 2022-07-14 | 2024-01-17 | BASF Agro B.V. | Verbessertes verfahren zum rückgewinnen von n,n-dimethylformamid (dmf) aus einem wässrigen prozessstrom |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4860613B2 (ja) * | 2004-07-22 | 2012-01-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 3−フェニル(チオ)ウラシル類およびジチオウラシル類を製造する方法 |
US20240174620A1 (en) | 2021-03-04 | 2024-05-30 | Adama Agan Ltd. | Solid forms of saflufenacil-sodium and saflufenacil-potassium, process of preparation and use thereof |
EP4313954A1 (de) | 2021-03-26 | 2024-02-07 | Adama Agan Ltd. | Herstellung von 2-chlor-4-fluor-5-nitrobenzoesäure |
CN115246791A (zh) * | 2021-04-26 | 2022-10-28 | 四川奥兰多化工有限公司 | 一种合成6-三氟甲基尿嘧啶的方法及其中间体 |
CN114478326B (zh) * | 2022-01-21 | 2023-10-03 | 安徽宁亿泰科技有限公司 | 一种苯嘧磺草胺关键中间体的合成方法 |
WO2024047648A1 (en) | 2022-08-31 | 2024-03-07 | Adama Agan Ltd. | Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989002891A1 (en) * | 1987-09-23 | 1989-04-06 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Heterocyclic compounds |
WO1998006706A1 (de) * | 1996-08-08 | 1998-02-19 | Bayer Aktiengesellschaft | Substituierte p-trifluormethylphenyluracile |
WO2001083459A2 (en) * | 2000-05-04 | 2001-11-08 | Basf Aktiengesellschaft | Uracil substituted phenyl sulfamoyl carboxamides |
WO2003097589A1 (de) * | 2002-05-16 | 2003-11-27 | Basf Aktiengesellschaft | Verfahren zur herstellung von sulfamidsäurehalogeniden |
WO2004039768A1 (de) * | 2002-10-30 | 2004-05-13 | Basf Aktiengesellschaft | Bifunktionelle phenyliso(thio)cyanate; verfahren und zwischenprodukte zu ihrer herstellung |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19755926A1 (de) | 1997-12-17 | 1999-06-24 | Basf Ag | Herbizide 3-(Benzazol-4-yl)pyrimidindion-Derivate |
ITMI20022758A1 (it) * | 2002-12-23 | 2004-06-24 | Isagro Ricerca Srl | Nuovi uracili ad attivita' erbicida. |
JP4860613B2 (ja) * | 2004-07-22 | 2012-01-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 3−フェニル(チオ)ウラシル類およびジチオウラシル類を製造する方法 |
-
2005
- 2005-07-13 JP JP2007521854A patent/JP4860613B2/ja active Active
- 2005-07-13 WO PCT/EP2005/007577 patent/WO2006010474A1/de active Application Filing
- 2005-07-13 CN CN200580024680XA patent/CN1989111B/zh active Active
- 2005-07-13 CA CA2574406A patent/CA2574406C/en active Active
- 2005-07-13 BR BRPI0513453-6A patent/BRPI0513453B1/pt active IP Right Grant
- 2005-07-13 AU AU2005266622A patent/AU2005266622B8/en active Active
- 2005-07-13 PL PL05763570T patent/PL1773787T3/pl unknown
- 2005-07-13 US US11/631,972 patent/US8252925B2/en active Active
- 2005-07-13 UA UAA200701779A patent/UA83764C2/ru unknown
- 2005-07-13 SI SI200531847T patent/SI1773787T1/sl unknown
- 2005-07-13 EP EP05763570.8A patent/EP1773787B1/de not_active Not-in-force
- 2005-07-13 KR KR1020077004099A patent/KR101238470B1/ko active IP Right Grant
- 2005-07-13 EA EA200700289A patent/EA012035B1/ru not_active IP Right Cessation
- 2005-07-13 ES ES05763570.8T patent/ES2465499T3/es active Active
- 2005-07-13 DK DK05763570.8T patent/DK1773787T3/da active
- 2005-07-13 MX MX2007000067A patent/MX2007000067A/es active IP Right Grant
- 2005-07-21 AR ARP050103026A patent/AR050005A1/es active IP Right Grant
-
2006
- 2006-12-19 IL IL180180A patent/IL180180A/en active IP Right Grant
-
2007
- 2007-02-20 ZA ZA200701464A patent/ZA200701464B/xx unknown
-
2011
- 2011-03-04 US US13/040,292 patent/US8124818B2/en active Active
- 2011-07-22 JP JP2011160861A patent/JP2012006936A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989002891A1 (en) * | 1987-09-23 | 1989-04-06 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Heterocyclic compounds |
WO1998006706A1 (de) * | 1996-08-08 | 1998-02-19 | Bayer Aktiengesellschaft | Substituierte p-trifluormethylphenyluracile |
WO2001083459A2 (en) * | 2000-05-04 | 2001-11-08 | Basf Aktiengesellschaft | Uracil substituted phenyl sulfamoyl carboxamides |
WO2003097589A1 (de) * | 2002-05-16 | 2003-11-27 | Basf Aktiengesellschaft | Verfahren zur herstellung von sulfamidsäurehalogeniden |
WO2004039768A1 (de) * | 2002-10-30 | 2004-05-13 | Basf Aktiengesellschaft | Bifunktionelle phenyliso(thio)cyanate; verfahren und zwischenprodukte zu ihrer herstellung |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8263806B2 (en) | 2005-12-01 | 2012-09-11 | Basf Se | Method for producing sulfonamides |
JP2010505918A (ja) * | 2006-10-13 | 2010-02-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 2−クロロ−5−[3,6−ジヒドロ−3−メチル−2,6−ジオキソ−4−(トリフルオロメチル)−1−(2h)−ピリミジニル]−4−フルオロ−n−[[メチル−(1−メチルエチル)アミノ]スルホニル]ベンズアミドの水和物 |
TWI423766B (zh) * | 2006-10-13 | 2014-01-21 | Basf Ag | 2-氯-5-〔3,6-二氫-3-甲基-2,6-二酮基-4-(三氟甲基)-1-(2h)-嘧啶基〕-4-氟-n-〔〔甲基(1-甲基乙基)胺基〕磺醯基〕苯甲醯胺之結晶型 |
EA015757B1 (ru) * | 2006-10-13 | 2011-12-30 | Басф Се | Гидраты 2-хлор-5-[3,6-дигидро-3-метил-2,6-диоксо-4-(трифторметил)-1-(2н)-пиримидинил]-4-фтор-n-[[метил-(1-метилэтил)амино]сульфонил]бензамида |
JP2010505917A (ja) * | 2006-10-13 | 2010-02-25 | ビーエーエスエフ ソシエタス・ヨーロピア | 2−クロロ−5−[3,6−ジヒドロ−3−メチル−2,6−ジオキソ−4−(トリフルオロメチル)−1−(2h)−ピリミジニル]−4−フルオロ−n−[[メチル−(1−メチルエチル)アミノ]スルホニル]ベンズアミドの結晶型 |
WO2008043836A1 (de) * | 2006-10-13 | 2008-04-17 | Basf Se | Hydrate des 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamids |
WO2008043835A3 (de) * | 2006-10-13 | 2008-07-03 | Basf Se | Kristalline form von 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamid |
EA015518B1 (ru) * | 2006-10-13 | 2011-08-30 | Басф Се | Кристаллическая форма 2-хлор-5-[3,6-дигидро-3-метил-2,6-диоксо-4-(трифторметил)-1-(2h)-пиримидинил]-4-фтор-n-[[метил-(1-метилэтил)амино]сульфонил]бензамида |
US8357695B2 (en) | 2006-10-13 | 2013-01-22 | Basf Se | Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide |
WO2008043835A2 (de) * | 2006-10-13 | 2008-04-17 | Basf Se | Kristalline form von 2-chlor-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluormethyl)-1-(2h)-pyrimidinyl]-4-fluor-n-[[methyl-(1-methylethyl)amino]sulfonyl]benzamid |
CN101535277B (zh) * | 2006-10-13 | 2014-06-25 | 巴斯夫欧洲公司 | 2-氯-5-[3,6-二氢-3-甲基-2,6-二氧代-4-(三氟甲基)-1-(2h)嘧啶基]-4-氟-n-[[甲基(1-甲基乙基)氨基]磺酰基]苯甲酰胺的结晶形式 |
CN101535278B (zh) * | 2006-10-13 | 2011-12-28 | 巴斯夫欧洲公司 | 2-氯-5-[3,6-二氢-3-甲基-2,6-二氧代-4-(三氟甲基)-1-(2h)嘧啶基]-4-氟-n-[[甲基(1-甲基乙基)氨基]磺酰基]苯甲酰胺的水合物 |
US8362026B2 (en) | 2006-10-13 | 2013-01-29 | Basf Se | Crystalline form of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methyl-ethyl)amino]sulfonyl]benzamide |
JP2011500536A (ja) * | 2007-10-12 | 2011-01-06 | ビーエーエスエフ ソシエタス・ヨーロピア | スルホン酸ジアミドの製法 |
US9920002B2 (en) | 2007-10-12 | 2018-03-20 | Basf Se | Methods for producing sulfonic acid diamides |
WO2009050120A1 (de) * | 2007-10-12 | 2009-04-23 | Basf Se | Verfahren zur herstelung von sulfonsäurediamiden |
CN103130727A (zh) * | 2013-02-27 | 2013-06-05 | 江苏省农用激素工程技术研究中心有限公司 | 苯嘧磺草胺中间体的制备方法 |
CN103130727B (zh) * | 2013-02-27 | 2015-07-08 | 江苏省农用激素工程技术研究中心有限公司 | 苯嘧磺草胺中间体的制备方法 |
WO2023017518A1 (en) | 2021-08-09 | 2023-02-16 | Adama Agan Ltd. | A new process of saflufenacil production using novel intermediates |
WO2023198484A1 (en) | 2022-04-12 | 2023-10-19 | BASF Agro B.V. | Improved process for recovering n,n-dimethylformamide (dmf) from an aqueous process stream |
EP4306508A1 (de) | 2022-07-14 | 2024-01-17 | BASF Agro B.V. | Verbessertes verfahren zum rückgewinnen von n,n-dimethylformamid (dmf) aus einem wässrigen prozessstrom |
Also Published As
Publication number | Publication date |
---|---|
BRPI0513453A (pt) | 2008-05-06 |
ZA200701464B (en) | 2009-03-25 |
DK1773787T3 (da) | 2014-06-23 |
AU2005266622B8 (en) | 2011-05-19 |
AR050005A1 (es) | 2006-09-20 |
UA83764C2 (ru) | 2008-08-11 |
CA2574406A1 (en) | 2006-02-02 |
BRPI0513453B1 (pt) | 2014-12-30 |
AU2005266622B2 (en) | 2011-03-31 |
ES2465499T3 (es) | 2014-06-05 |
EP1773787B1 (de) | 2014-04-02 |
EA200700289A1 (ru) | 2007-08-31 |
PL1773787T3 (pl) | 2014-09-30 |
AU2005266622A1 (en) | 2006-02-02 |
US20080033174A1 (en) | 2008-02-07 |
US20110152522A1 (en) | 2011-06-23 |
US8124818B2 (en) | 2012-02-28 |
CN1989111A (zh) | 2007-06-27 |
JP2012006936A (ja) | 2012-01-12 |
CA2574406C (en) | 2013-02-19 |
JP2008506733A (ja) | 2008-03-06 |
MX2007000067A (es) | 2007-03-28 |
KR101238470B1 (ko) | 2013-03-04 |
KR20070034127A (ko) | 2007-03-27 |
US8252925B2 (en) | 2012-08-28 |
EP1773787A1 (de) | 2007-04-18 |
IL180180A0 (en) | 2007-06-03 |
EA012035B1 (ru) | 2009-06-30 |
SI1773787T1 (sl) | 2014-05-30 |
JP4860613B2 (ja) | 2012-01-25 |
CN1989111B (zh) | 2012-12-05 |
IL180180A (en) | 2011-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1773787B1 (de) | Verfahren zur herstellung von 3-phenyl(thio)uracilen und - dithiouracilen | |
EP1697309B1 (de) | Benzoylsubstituierte phenylalanin-amide | |
EP1791825B1 (de) | Benzoylsubstituierte serin-amide | |
WO2005061464A1 (de) | Herbizide heteroaroyl-substituierte phenylalanin-amide | |
EP1791829A1 (de) | Heteroaroylsubstituierte serinamide als herbizide | |
JP2003501408A (ja) | 2,2,4,4−四置換された1,3,5−シクロヘキサントリオンの製造方法 | |
KR100766637B1 (ko) | β케토에놀 에스테르의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005763570 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 180180 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3861/KOLNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/000067 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11631972 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007521854 Country of ref document: JP Ref document number: 2574406 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005266622 Country of ref document: AU Ref document number: 200580024680.X Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200701464 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077004099 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200700289 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2005266622 Country of ref document: AU Date of ref document: 20050713 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005266622 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1020077004099 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005763570 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11631972 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 11631972 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: PI0513453 Country of ref document: BR |